Emily Soo Hyun Hong

Clinical Trial Liaison

Role: Clinical Trial Liaison at Cour Pharma
Location: Concord, CA, US
LinkedIn followers: 500 followers

ScienceView LinkedIn profile

Experience

Clinical Trial Liaison
Cour Pharma
Mar 2025 — Present

Education

University of the Pacific
Pre-pharmacy
2016 — 2019
University of the Pacific - Thomas J. Long School of Pharmacy
Doctor of Pharmacy - PharmD, Pharmacy
2019 — 2022

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@courpharma.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Cour Pharma

Biotechnology Research · 61 employees · Founded 2015 · Evanston, Illinois, United States

COUR is a clinical-stage biotechnology company working to reprogram the immune system to restore health in people suffering from autoimmune diseases. Using our proprietary COUR nanoparticle (CNP) platform for antigen-specific immune tolerance, we develop first-in-class disease-modifying therapies that target disease at its root—without suppressing normal immune system function. With programs in primary biliary cholangitis (PBC), type 1 diabetes (T1D), myasthenia gravis (MG), and celiac disease, COUR is advancing a new standard for immune-modifying therapies.

courpharma.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Experience

Clinical Trial Liaison

Education

University of the Pacific

University of the Pacific - Thomas J. Long School of Pharmacy

Find verified contacts for anyone on LinkedIn